Evidence map›Paper›PMID 41020255›Full record

ArticleBiomedical reports2025

Exon 4 and intron 4

Wiktor Szewczuk, Oksana Szewczuk, Krzysztof Czajkowski, Robert Gromadka, Maciej Waledziak, Marek Semczuk, Andrzej Semczuk

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedical reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The p53 Isoforms as Potential Biomarkers in Different Cancer Entities.International journal of molecular sciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wiktor SzewczukDepartment of Pathology, Military Institute of Medicine, 04-141 Warsaw, Poland.
Oksana SzewczukIInd Department of Obstetrics and Gynecology, Warsaw Medical University, 00-315 Warsaw, Poland.
Krzysztof CzajkowskiIInd Department of Obstetrics and Gynecology, Warsaw Medical University, 00-315 Warsaw, Poland.
Robert GromadkaLaboratory of DNA Sequencing and Oligonucleotide Synthesis, Institute of Biochemistry and Biophysics Polish Academy of Sciences, 02-106 Warsaw, Poland.
Maciej WaledziakDepartment of Surgery, Military Institute of Medicine, 04-141 Warsaw, Poland.
Marek SemczukIInd Department of Gynecological Surgery and Gynecological Oncology, Lublin Medical University, 20-950 Lublin, Poland.
Andrzej SemczukIInd Department of Gynecological Surgery and Gynecological Oncology, Lublin Medical University, 20-950 Lublin, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although intragenic CpG dinucleotides are conserved during evolution, they are also sensitive to methylation-dependent mechanisms. Methylation status of the

Indexed as

exon 4intron 4methylationovarian cancerTP53

Identifiers

PMID41020255
PMCPMC12464476

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.